Current Status of Stem Cell Therapies in Tissue Repair and Regeneration

Author(s): Tapan Kumar Giri, Amit Alexander*, Mukta Agrawal, Swarnalata Saraf, Shailendra Saraf, Ajazuddin.

Journal Name: Current Stem Cell Research & Therapy

Volume 14 , Issue 2 , 2019

Become EABM
Become Reviewer

Abstract:

Tissue engineering is a multi-disciplinary field such as material science, life science, and bioengineering that are necessary to make artificial tissue or rejuvenate damaged tissue. Numerous tissue repair techniques and substitute now exist even though it has several shortcomings; these shortcomings give a good reason for the continuous research for more acceptable tissue-engineered substitutes. The search for and use of a suitable stem cell in tissue engineering is a promising concept. Stem cells have a distinctive capability to differentiate and self-renew that make more suitable for cell-based therapies in tissue repair and regeneration. This review article focuses on stem cell for tissue engineering and their methods of manufacture with their application in nerve, bone, skin, cartilage, bladder, cardiac, liver tissue repair and regeneration.

Keywords: Tissue engineering, stem cell-based therapy, totipotent, pluripotent, mesenchymal stem cells, liver tissue regeneration.

[1]
Liu H, Webster TJ. Mechanical properties of dispersed ceramic nanoparticles in polymer composites for orthopedic applications. Int J Nanomedicine 2010; 5: 299-313.
[2]
Titorencu I, Albu MG, Nemecz M, Jinga VV. Natural polymer-cell bioconstructs for bone tissue engineering. Curr Stem Cell Res Ther 2017; 12(2): 165-74.
[3]
Iordache F, Grumezescu AM, Maniu H, Curutiu C. Development of scaffolds for vascular tissue engineering: Biomaterial mediated neovascularization. Curr Stem Cell Res Ther 2017; 12(2): 155-64.
[4]
Stock UA, Vacanti JP. Tissue engineering: Current state and prospects. Annu Rev Med 2001; 52: 443-51.
[5]
Shaunak S, Dhinsa BS, Khan WS. The role of 3D modelling and printing in orthopaedic tissue engineering: A review of the current literature. Curr Stem Cell Res Ther 2017; 12(3): 225-32.
[6]
Yi S, Ding F, Gong L, Gu X. Extracellular matrix scaffolds for tissue engineering and regenerative medicine. Curr Stem Cell Res Ther 2017; 12(3): 233-46.
[7]
Ariffin SH, Manogaran T, Abidin IZ, Wahab RM, Senafi S. A perspective on stem cells as biological systems that produce differentiated osteoblasts and odontoblasts. Curr Stem Cell Res Ther 2017; 12(3): 247-59.
[8]
Sinclair KL, Mafi P, Mafi R, Khan WS. The use of growth factors and mesenchymal stem cells in orthopaedics: In particular, their use in fractures and non-unions: A systematic review. Curr Stem Cell Res Ther 2017; 12(4): 312-25.
[9]
Green RM. Can we develop ethically universal embryonic stem-cell lines? Nat Rev Genet 2007; 8(6): 480-5.
[10]
Mitalipov S, Wolf D. Totipotency, pluripotency and nuclear reprogramming. Adv Biochem Eng Biotechnol 2009; 114: 185-99.
[11]
Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418(6893): 41-9.
[12]
Ratajczak MZ, Machalinski B, Wojakowski W, Ratajczak J, Kucia M. A hypothesis for an embryonic origin of pluripotent Oct-4(+) stem cells in adult bone marrow and other tissues. Leukemia 2007; 21(5): 860-7.
[13]
Narasipura SD, Wojciechowski JC, Duffy BM. L Liesveld J, King MR. Purification of CD45+ hematopoietic cells directly from human bone marrow using a flow-based P-selectin-coated microtube. Am J Hematol 2008; 83(8): 627-9.
[14]
Caplan AI. Mesenchymal stem cells. J Orthop Res 1991; 9(5): 641-50.
[15]
Caplan AI. The mesengenic process. Clin Plast Surg 1994; 21(3): 429-35.
[16]
Huang GT, Gronthos S, Shi S. Mesenchymal stem cells derived from dental tissues vs. those from other sources: Their biology and role in regenerative medicine. J Dent Res 2009; 88(9): 792-806.
[17]
Mishra PK, Kuypers NJ, Singh SR, Leiberh ND, Chavali V, Tyagi SC. Cardiac stem cell niche, MMP9, and culture and differentiation of embryonic stem cells. Methods Mol Biol 2013; 1035: 153-63.
[18]
Colter DC, Class R, DiGirolamo CM, Prockop DJ. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA 2000; 97(7): 3213-8.
[19]
Morgani SM, Canham MA, Nichols J, et al. Totipotent embryonic stem cells arise in ground-state culture conditions. Cell Reports 2013; 3(6): 1945-57.
[20]
Priest RE, Marimuthu KM, Priest JH. Origin of cells in human amniotic fluid cultures: ultrastructural features. Lab Invest 1978; 39(2): 106-9.
[21]
De Coppi P, Bartsch G Jr, Siddiqui MM, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007; 25(1): 100-6.
[22]
Houlihan JM, Biro PA, Harper HM, Jenkinson HJ, Holmes CH. The human amnion is a site of MHC class Ib expression: Evidence for the expression of HLA-E and HLA-G. J Immunol 1995; 154(11): 5665-74.
[23]
Taylor A, Verhagen J, Blaser K, Akdis M, Akdis CA. Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: The role of T regulatory cells. Immunology 2006; 117(4): 433-42.
[24]
Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13(12): 4279-95.
[25]
Halvorsen YD, Franklin D, Bond AL, et al. Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells. Tissue Eng 2001; 7(6): 729-41.
[26]
Huang JI, Zuk PA, Jones NF, et al. Chondrogenic potential of multipotential cells from human adipose tissue. Plast Reconstr Surg 2004; 113(2): 585-94.
[27]
Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 2001; 7(2): 211-28.
[28]
Mizuno H, Zuk PA, Zhu M, Lorenz HP, Benhaim P, Hedrick MH. Myogenic differentiation by human processed lipoaspirate cells. Plast Reconstr Surg 2002; 109(1): 199-209. discussion 10-1
[29]
Rangappa S, Fen C, Lee EH, Bongso A, Sim EK. Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes. Ann Thorac Surg 2003; 75(3): 775-9.
[30]
Zhao Y, Glesne D, Huberman E. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci USA 2003; 100(5): 2426-31.
[31]
Ruhnke M, Ungefroren H, Nussler A, et al. Differentiation of in vitro-modified human peripheral blood monocytes into hepatocyte-like and pancreatic islet-like cells. Gastroenterology 2005; 128(7): 1774-86.
[32]
Saha K, Irwin EF, Kozhukh J, Schaffer DV, Healy KE. Biomimetic interfacial interpenetrating polymer networks control neural stem cell behavior. J Biomed Mater Res A 2007; 81(1): 240-9.
[33]
Su H, Wang L, Cai J, et al. Transplanted motoneurons derived from human induced pluripotent stem cells form functional connections with target muscle. Stem Cell Res 2013; 11(1): 529-39.
[34]
Nicolas CT, Hickey RD, Chen HS, et al. Concise Review: Liver regenerative medicine: from hepatocyte transplantation to bioartificial livers and bioengineered grafts. Stem Cells 2017; 35(1): 42-50.
[35]
Wang Y, Zhang Y, Zhang S, et al. Rotating microgravity-bioreactor cultivation enhances the hepatic differentiation of mouse embryonic stem cells on biodegradable polymer scaffolds. Tissue Eng Part A 2012; 18(21-22): 2376-85.
[36]
Yannaki E, Anagnostopoulos A, Kapetanos D, et al. Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells. Exp Hematol 2006; 34(11): 1583-7.
[37]
Kharaziha P, Hellstrom PM, Noorinayer B, et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: A phase I-II clinical trial. Eur J Gastroenterol Hepatol 2009; 21(10): 1199-205.
[38]
Salama H, Zekri AR, Zern M, et al. Autologous hematopoietic stem cell transplantation in 48 patients with end-stage chronic liver diseases. Cell Transplant 2010; 19(11): 1475-86.
[39]
Salomone F, Barbagallo I, Puzzo L, Piazza C, Li Volti G. Efficacy of adipose tissue-mesenchymal stem cell transplantation in rats with acetaminophen liver injury. Stem Cell Res 2013; 11(3): 1037-44.
[40]
Alexandru N, Costa A, Constantin A, Cochior D, Georgescu A. Microparticles: From biogenesis to biomarkers and diagnostic tools in cardiovascular disease. Curr Stem Cell Res Ther 2017; 12(2): 89-102.
[41]
Rosca AM, Rayia DM, Tutuianu R. Emerging role of stem cells - derived exosomes as valuable tools for cardiovascular therapy. Curr Stem Cell Res Ther 2017; 12(2): 134-8.
[42]
Martinez EC, Kofidis T. Adult stem cells for cardiac tissue engineering. J Mol Cell Cardiol 2011; 50(2): 312-9.
[43]
Clause KC, Tinney JP, Liu LJ, et al. A three-dimensional gel bioreactor for assessment of cardiomyocyte induction in skeletal muscle-derived stem cells. Tissue Eng Part C Methods 2010; 16(3): 375-85.
[44]
Janssens S, Dubois C, Bogaert J, et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006; 367(9505): 113-21.
[45]
Zimmermann WH, Melnychenko I, Wasmeier G, et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 2006; 12(4): 452-8.
[46]
Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002; 106(15): 1913-8.
[47]
Tse HF, Kwong YL, Chan JK, Lo G, Ho CL, Lau CP. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003; 361(9351): 47-9.
[48]
Assmus B, Schachinger V, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002; 106(24): 3009-17.
[49]
Zhang J, Chen J. Bone tissue regeneration - application of mesenchymal stem cells and cellular and molecular mechanisms. Curr Stem Cell Res Ther 2017; 12(5): 357-64.
[50]
Nokhbatolfoghahaei H, Rad MR, Khani MM, Shahriari S, Nadjmi N, Khojasteh A. Application of bioreactors to improve functionality of bone tissue engineering constructs: A systematic review. Curr Stem Cell Res Ther 2017; 12(7): 564-99.
[51]
Zhou Q, Yang C, Yang P. The promotional effect of mesenchymal stem cell homing on bone tissue regeneration. Curr Stem Cell Res Ther 2017; 12(5): 365-76.
[52]
Saleh FA, Whyte M, Genever PG. Effects of endothelial cells on human mesenchymal stem cell activity in a three-dimensional in vitro model. Eur Cell Mater 2011; 22: 242-57. discussion 57
[53]
Quarto R, Mastrogiacomo M, Cancedda R, et al. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 2001; 344(5): 385-6.
[54]
Lee EH, Hui JH. The potential of stem cells in orthopaedic surgery. J Bone Joint Surg Br 2006; 88(7): 841-51.
[55]
Hutton DL, Grayson WL. Stem cell-based approaches to engineering vascularized bone. Curr Opin Chem Eng 2014; 3(Suppl. C): 75-82.
[56]
Maranda EL, Rodriguez-Menocal L, Badiavas EV. Role of mesenchymal stem cells in dermal repair in burns and diabetic wounds. Curr Stem Cell Res Ther 2017; 12(1): 61-70.
[57]
Ma T, Wang X, Jiang D. Immune tolerance of mesenchymal stem cells and induction of skin allograft tolerance. Curr Stem Cell Res Ther 2017; 12(5): 409-15.
[58]
Guenou H, Nissan X, Larcher F, et al. Human embryonic stem-cell derivatives for full reconstruction of the pluristratified epidermis: a preclinical study. Lancet 2009; 374(9703): 1745-53.
[59]
Brzoska M, Geiger H, Gauer S, Baer P. Epithelial differentiation of human adipose tissue-derived adult stem cells. Biochem Biophys Res Commun 2005; 330(1): 142-50.
[60]
Kaisang L, Siyu W, Lijun F, Daoyan P, Xian CJ, Jie S. Adipose-derived stem cells seeded in Pluronic F-127 hydrogel promotes diabetic wound healing. J Surg Res 2017; 217: 63-74.
[61]
Kanematsu A, Yamamoto S, Iwai-Kanai E, et al. Induction of smooth muscle cell-like phenotype in marrow-derived cells among regenerating urinary bladder smooth muscle cells. Am J Pathol 2005; 166(2): 565-73.
[62]
Chung SY, Krivorov NP, Rausei V, et al. Bladder reconstitution with bone marrow derived stem cells seeded on small intestinal submucosa improves morphological and molecular composition. J Urol 2005; 174(1): 353-9.
[63]
Zhang Y, Lin HK, Frimberger D, Epstein RB, Kropp BP. Growth of bone marrow stromal cells on small intestinal submucosa: an alternative cell source for tissue engineered bladder. BJU Int 2005; 96(7): 1120-5.
[64]
Zhang M, Peng Y, Zhou Z, Zhou J, Wang Z, Lu M. Differentiation of human adipose-derived stem cells co-cultured with urothelium cell line toward a urothelium-like phenotype in a nude murine model. Urology 2013; 81(2): 465.e15-22.
[65]
Loai Y, Yeger H, Coz C, et al. Bladder tissue engineering: Tissue regeneration and neovascularization of HA-VEGF-incorporated bladder acellular constructs in mouse and porcine animal models. J Biomed Mater Res A 2010; 94(4): 1205-15.
[66]
Zhang J, Du C, Guo W, et al. Adipose tissue-derived pericytes for cartilage tissue engineering. Curr Stem Cell Res Ther 2017; 12(6): 513-21.
[67]
Wakitani S, Goto T, Pineda SJ, et al. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am 1994; 76(4): 579-92.
[68]
Wakitani S, Mitsuoka T, Nakamura N, Toritsuka Y, Nakamura Y, Horibe S. Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports. Cell Transplant 2004; 13(5): 595-600.
[69]
Wakitani S, Imoto K, Yamamoto T, Saito M, Murata N, Yoneda M. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage 2002; 10(3): 199-206.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 14
ISSUE: 2
Year: 2019
Page: [117 - 126]
Pages: 10
DOI: 10.2174/1574888X13666180502103831
Price: $58

Article Metrics

PDF: 39
HTML: 5